Copyright
©The Author(s) 2018.
World J Gastroenterol. May 21, 2018; 24(19): 2073-2082
Published online May 21, 2018. doi: 10.3748/wjg.v24.i19.2073
Published online May 21, 2018. doi: 10.3748/wjg.v24.i19.2073
Figure 1 Role of osteoprotegerin/ receptor activator of nuclear factor-B ligand/receptor activator of nuclear factor kappa B axis in physiological and pathophysiological conditions.
- Citation: Pacifico L, Andreoli GM, D’Avanzo M, De Mitri D, Pierimarchi P. Role of osteoprotegerin/receptor activator of nuclear factor kappa B/receptor activator of nuclear factor kappa B ligand axis in nonalcoholic fatty liver disease. World J Gastroenterol 2018; 24(19): 2073-2082
- URL: https://www.wjgnet.com/1007-9327/full/v24/i19/2073.htm
- DOI: https://dx.doi.org/10.3748/wjg.v24.i19.2073